Osimertinib OverviewOsimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. Osimertinib was approved for medical use in the United States in November 2015, and in the European Union in February 2016. Contents 1 Medical uses 2 Adverse effects 3 Interaction...
Read more Osimertinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Osimertinib
Recent Osimertinib Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 40mg, 80mg
Other drugs which contain Osimertinib or a similar ingredient: (1 result)
- TAGRISSO Osimertinib